glp-1 uses The Ultimate Guide to GLP-1: Basics, Benefits, and More GLP-1 Agonists - What is

The use of behavioral health services decreased dramatically for patients prescribed GLP-1 drugs during the study period

SGLT-2 inhibitors: the gap seems to be leveling off

doi: 10.1186/s12933-018-0790-0

As the GLP-1 landscape continues to evolve, the goal is no longer simply deciding whether to cover these medicationsbut determining how to maximize their value for both employees and employer-sponsored health plans.

A 6-month course of GLP-1 agonist therapy led to reduced appetite scores and lower levels of glycosylated hemoglobin (HbA1c) in a group of 10 patients with the condition, although no significant changes were observed in body weight, BMI, adiposity, or ghrelin levels [51]

This analysis concludes that while GLP-1 agonists demonstrate significant promise, their ultimate impact depends on addressing cost, accessibility, and long-term sustainability concerns